Topic Listing for Caliper Life Sciences

A-2 Sheet Abatement
Accounting Estimates Incorrect Financial Results Adversely Affected Accounting Goodwill Other Intangible Assets Material Adverse Effect
Accounting Goodwill Other Intangible Assets Significant Adverse Effect Accounts Receivable Reserves
Accrued Salary Paid Time Off Acknowledgements
Acquisition Equity Incentive Plan Acquisitions
Acquisitions Unexpected Consequences Impose Additional Costs Action Without Meeting
Additional Events Deemed Assignment Sublet Additional Rent
Adjournment Notice Adjourned Meetings Adjusted Quick Ratio
Adjusted Results Adjustment Provisions
Adjustments Administration
Administration Board Admissions
Advertising Expense Affidavit Mailing
Affiliate Agented Loan Arrangement
Agents Agreement
Agreements Relating Transfer Transferred Assets Allan Comstock
Allocation Amended Restated 2008
Amended Restated Loan Security Agreement Amendment Plan
Amendment Stock Awards Amendment Termination
Amendments Amortization Intangible Assets
Andrea Chow Phd Animal Production
Annual Grants Annual Meetings
Annual Performance Cash Bonus Program Annual Performance Review Process
Anticancer Applicable Law
Approval Amendments 1999 Non-employee Directors Equity Incentive Plan Appurtenant Rights Landlord Reservations
Apw Active Pharmaceutical Ingredient Workstation Asset Purchase Agreement
Assets Assignment
Assignment Client Work Product Assignment Subletting Bonus Rent Paragraph Lease Amended Deleting
Assistance Assumption Liabilities
Audit Committee Audit Fees
Audit-related Fees Auro Nair Phd
Authority Authority Binding Nature Agreements
Automatic Grants Automation
Automation Liquid Handling Automation Liquid Handling Systems
Autotrace Employee Autotrace Offering
Autotrace Product Autotrace Product Line Divestiture
Availability Shares Available Stock Awards
Awards Background Plan
Backlog Base Salary
Basic Data Basic Rent
Basis Presentation Because Receive Revenue Principally Pharmaceutical Biotechnology Chemical Companies
Been Manufactured Not Delivered Sales Price Only Partly Been Sued Risk Future Securities Class Action Litigation
Beneficial Owner Shares Registered Name Broker Bank Beneficial Ownership Reporting Compliance
Between Borrower Bank Acknowledges Confirms Agrees Disclosures Information Binding Nature Agreements
Biophotonic Cameras Bioware Products-light-producing Cells Microorganisms
Board Directors Recommends Vote Board Directors Recommends Vote Favor Proposal
Bradley Rice Phd Bruce Bal
Building Building Expansions
Buildings Business
Business Realignment Business Stock Price Adversely Affected Acquisition Xenogen Not
Caliper Caliper Board Directors Related Matters
Caliper Driven Program Caliper Initial Public Offering
Caliper Life Sciences Caliper Life Sciences Announces Preliminary 2008 Full Revenue
Caliper Life Sciences Announces Preliminary Results 2009 Caliper Life Sciences Inc
Caliper Life Sciences Inc Certification Pursuant Usc 1350 Caliper Life Sciences Inc Elm Street Hopkinton 01748
Caliper Life Sciences Inc Subsidiaries 2006 Caliper Life Sciences Present Jpmorgan Annual Healthcare Conference
Caliper Life Sciences Receives Task Order Epas Toxcast Caliper Life Sciences Reports 2006 Financial Results
Caliper Life Sciences Reports 2007 Financial Results Caliper Life Sciences Reports 2008 Results
Caliper Life Sciences Reports 2009 Results Caliper Life Sciences Reports Full 2006 Results
Caliper Life Sciences Reports Full 2007 Results Caliper Life Sciences Reports Full 2008 Results
Caliper Life Sciences Reports West Coast Consolidation Operations Caliper Performance Bonus Plan
Caliper Sciclone Caliper Screens Compounds Detect Toxicity
Caliper Technologies Corp Initial Public Offering Securities Litigation Capital Requirements
Capitalization Adjustments Cash Equivalents Marketable Securities
Cash Flows Cdas
Certain Relationships Related Transactions Certain Relationships Related Transactions Director Independence
Certification Certification Chief Executive Officer
Certification Chief Executive Officer Pursuant Rule 13a-14 15d-14 Certification Chief Financial Officer
Certification Chief Financial Officer Pursuant Rule 13a-14 15d-14 Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act
Change Control Severance Plan Change Control-dissolution Liquidation
Change Vote After Submitting Proxy Changes Internal Controls
Chief Financial Officer Chip Design
Chip Manufacturing Choice Law Venue Jury Trial Waiver Judicial Reference
Choice Specified Proxy Voted Claim
Classes Directors Closing
Code Business Conduct Ethics Code Ethics
Collection Rent Commitments Contingencies
Common Shares Outstanding Common Stock
Common Stock Purchase Rights Comparison Cumulative Total Return Assumes Initial Investment 100
Compensation Compensation Committee
Compensation Committee Interlocks Insider Participation Compensation Committee Report
Compensation Components Compensation Directors
Compensation Methodology Competition
Complete Only Portion Funds Loan Advance Above Wired Complete Understanding Modification
Completes Restructuring Divestitures Non-core Product Lines Completion Acquisition Disposition Assets
Compliance 409a Code Compliance Certificate
Compliance Governmental Regulations Increase Operating Costs Adversely Affect Compliance Legal Requirements
Comprehensive Income Loss Comprehensive Loss
Conclusion Condition Premises
Conditions Effectiveness Assignment Sublet Confidentiality
Conflict Interest Consent
Consent Independent Registered Public Accounting Firm Consents
Consideration Consistent Changes Existing Loan Documents Hereby Amended Wherever
Consolidation Consolidation Plan
Construction Consulting Agreement
Consulting Agreements Consulting Other Agreements
Contamination Animal Populations Damage Inventory Harm Reputation Result Contingent Change Directors Cash Compensation
Continuing Access Information Contract
Contract Research Transgenic Animal Services Contract Revenue
Contracts Contractual Obligations
Controls Procedures Copy Calipers Annual Report Securities Exchange Form 10-k
Corporate Seal Cost License Revenue
Cost Product Revenue Cost Reduction Initiatives
Cost Revenue Cost Service Revenue
Costs Associated Exit Disposal Activities Costs Revenue
Counterparts Exchanges Electronic Transmission Facsimile Covenant Default
Covenant Deliver Creation Direct Financial Obligation Off-balance Sheet Arrangement
Creation Genetically-modified Animals Credit Facility
Credit Facility Other Long-term Obligations Credit Facility Subsequent Event
Critical Accounting Estimates Critical Accounting Policies Estimates
Current Oem Partners Include Customer Accounts Receivable
Customer Facility Customers
Damages Daniel Kisner
Data Source Standard Poors Research Insight 2008 David Carter
David Manyak Phd David Milligan Phd
Deadline Deadline Same Processing Noon Est
Death Participant Declaration Dividends
Declines Employment Purchaser Not Become Transferred Employee Hereunder Default Tenant
Defense Party Claims Deferred Rent
Definitions Definitions Used Agreement Following Terms Meanings
Delaware Delegation Authority
Departure Directors Certain Officers Election Appointment Compensatory Departure Directors Principal Officers Election Appointment
Depend Limited Number Suppliers Components Ivis Imaging Systems Derived Audited Financial Statements 2006
Derived Audited Financial Statements 2007 Description Change Terms
Desktop Profiler Kinase Profiling System Determine Employees Directors Consultants Shall Granted Stock Rights
Dionex Corporation Direct Sales
Director Continuing Office Until 2011 Annual Meeting Directors Continuing Office Until 2008 Annual Meeting
Directors Continuing Office Until 2009 Annual Meeting Directors Continuing Office Until 2010 Annual Meeting
Directors Executive Officers Directors Executive Officers Corporate Governance
Disability Participant Disclosure Schedule
Disclosure Work Product Discovery Products Services Growth
Dispute Resolution Procedures Distributors
Dividend Reserve Dividends
Documents Documents Incorporated Reference
Drug Development Solutions Drug Discovery Development Services
Drug Discovery Services Drug Discovery Solutions
Due Organization Duration Amendment Termination
Duties Chairman Board Directors Duties Chief Executive Officer
Duties Chief Financial Officer Duties President
Duties Secretary Duties Vice Presidents
Ecurities Exchange Act 1934 Effect Boards Decision
Effect Change Control Effect Equity Awards Merger Liquidation
Effect Termination Election Director
Election Directors Eligibility
Eligible Stock Award Recipients Elm Street Hopkinton 01748
Elm Street Hopkinton 01748 Address Principal Executive Offices Elm Street Hopkinton Massachusetts 01748
Elm Street Hopkinton Massachusetts 01748 Address Zip Code Emerging Issues Task Force Eitf Issue 00-21 Revenue
Employee Labor Matters Employees
Employment Agreement Hrusovsky Employment Agreement Kisner
Employment Severance Change Control Agreements Encumbrance
Enforcement Enforcement Proprietary Rights
Engagement Services Enrique Bernal
Entire Agreement Entity
Entry Material Definitive Agreement Enumeration Exhibits
Environmental Matters Equipment Fixed Assets
Establishment Confidential Relationship Estimates
Evaluation Disclosure Controls Procedures Events Default
Excess Payments Execution Corporate Instruments
Execution Documents Execution Other Securities
Executive Committee Executive Compensation
Executive Officers Key Employees Executive Officers Registrant
Exercise Price Exercise Price Payment
Exhibits Exhibits Financial Statement Schedules
Expect Incur Future Operating Losses Not Achieve Profitability Expense Reimbursements
Expenses Expiration Date
Explanatory Export
Extension Termination Date Extra Hazardous
Face Competition Companies Established Technologies Vivo Biological Assessment Facility Closures
Failure Maintain Credit Facility Borrowing Base Raise Additional Failure Raise Additional Capital Generate Significant Necessary Expand
Failure Receive Notice Failure Remain Compliance Covenants Included Revolving Credit Facility
Fair Value Financial Instruments Features Labchip System
Features Labchip Systems Federal Income Tax Consequences
Federal Income Tax Information Fees Borrower Shall Pay Bank
Fees Compensation Fees Expenses
Fees Services Agreement Financial Covenants
Financial Covenants Borrower Financial Performance
Financial Projections Financial Statement Presentation
Financial Statement Presentation Principles Consolidation Financial Statements Customers
Financial Statements Exhibits Financial Statements Reports Certificates
Financial Statements Supplementary Data Financing Activities
Find Out Results Voting Annual Meeting Fixing Record Dates
Following Shall Added End Paragraph Force Majeure
Foreign Currency Foreign Currency Translation
Form 10-k Form 10-q
Form Execution Certificates Form Transition Services Agreement
Forms Partnership Expand Customer Access Light Producing Animal Full Disclosure
Further Actions Further Release
Future Revenue Growth Depends Significant Extent Novascreen Business Future Revenue Growth Depends Significant Extent Novascreen Recently
Future Revenue Unpredictable Cause Operating Results Fluctuate Significantly Gaap Guidance
General General Liability Insurance
General Overview General Policy
General Purpose General Release
Genetically Modified Animals Goodwill
Governing Law Governing Law Severability
Governing Law Venue Government Contracts
Government Regulation Governmental Authority
Governmental Authorization Governmental Authorizations
Governmental Body Grants Plan-based Awards
Gross Margins Guarantees Indemnifications
Guidance Hazardous Materials
Hazardous Materials Business Claims Relating Improper Handling Storage Headings
Health Insurance Held 2007
Held 2008 Held 2009
Highlights Holding Over
Hopkinton 01748 Hopkinton Massachusetts 01748
Householding Annual Disclosure Documents Imaging
Imaging Instrumentation Software Imaging Product Line
Imaging Systems Impact Inflation
Impairment Impairment Long-lived Assets
Impairment Rights Important Notice
Important Notice Regarding Availability Proxy Materials Stockholder Meeting Improper Materials
In-license Obligations Income Taxes
Indebtedness Management Indemnification Agreements
Indemnification Seller Indemnitees
Independence Board Directors Independent Contractor
Independent Contractor Relationship Index
Index Exhibits Information Regarding Audit Committee
Information Regarding Board Directors Committees Information Regarding Forward-looking Statements
Initial Compensation Determinations Initial Grants
Initial Public Offering Securities Litigation Injunctive Relief
Inserting Lieu Thereof Following Insurance
Intangibles Intellectual Property
Intellectual Property Rights Intellectual Property Rights Not Provide Meaningful Commercial Protection
Interest Expense Interest Expense Net
Interest Income Interest Income Expense Net
Interest Income Net Interest Other Expense Net
Interest Other Income Expense Net Interest Other Income Expenses
Interest Rate Sensitivity Introduction
Inventories Inventory
Inventory Material Respects Good Marketable Quality Free Defects Inventory Purchases
Inventory Reserves Investing Activities
Investment Assurances Ivis Imaging Systems Cross 500 Placement Milestone
Ivis Imaging Systems Living Image Software Jean-louis Rufener
John Dellisanti Joinder Agreement
Joint Owners Stock Joseph Griffith Promoted Vice President Finance
Kathryn Tunstall Kevin Hrusovsky
Key Benefits Labchip Systems Knowledge
Labchip 3000 Drug Discovery System Labchip Automated Electrophoresis System
Labchip Drug Discovery Labchip Electrophoresis Separations
Labchip Products Not Achieve Widespread Market Acceptance Cause Land
Landlord Landlord Insurance
Landlords Address Landlords Contribution
Landlords Liability Landlords Managing Agent
Landlords Obligations Landlords Remedies
Landlords Right Termination Landlords Work
Lease Lease Amendments
Lease Premises Lease Term Initial Being Extended Period Accordingly Existing
Leases Legal Equitable Remedies
Legal Fees Legal Proceedings
Legal Requirement Legal Settlement
Letter Credit Letter Credit Automatic Annual 200000 Reduction Feature Per
Letters Credit Sublimit Letters-of-credit
Liability License Fees Contract Revenue
License Obligations Contingencies License Royalty Fees
Licensing Royalty Light-producing Animal Models
Light-producing Reagents Limitation Awards Shares Available
Limitations Effectiveness Disclosure Controls Procedures Liquid Handling Automation Instrument Manufacturing Software Design
Liquidity Capital Resources List Stockholders
Litigation Loan Advance
Loan Modification Agreement Loan Security Agreement
Long-term Incentives Lost Certificates
Lpta Animal Models Management Host Conference Call Today 900 Edt Discuss
Managements Discussion Analysis Financial Condition Results Operations Managements Report Internal Control Over Financial Reporting
Manufacturing Supply Market Information
Market Opportunity Market Registrants Common Equity Related Stockholder Matters Issuer
Marketing Agreements Meetings
Meetings Board Directors Methods Notice
Michael Eisenson Microfluidics
Microfluidics Laboratory Automation Microfluidics Systems
Miscellaneous Multidose
Multiple Element Arrangements Negative Covenants
Net Loss Narrowed 007 Per Share Net Loss Per Share
Net Loss Per Weighted Average Common Share Outstanding New Directors Following Merger See Page I-107
New Patent Covers Important Classes Fluorescent Bioluminescent Vivo New Plan Benefits
Nominating Corporate Governance Committee Nominee Election Three-year Term Expiring 2011 Annual Meeting
Nominees Election Three-year Term Expiring 2010 Annual Meeting Non-cash Restructuring Goodwill Impairment Charge 453 Recognized
Non-contravention Consents Non-employee Director Compensation Policy
Non-exclusivity Rights Non-gaap Financial Measures
Non-statutory Stock Option Plan Non-statutory Stock Option Plan 2001
Noncompetition Nondisclosure Third-party Information
Nondisparagement Noninterference Business
Nonqualified Deferred Compensation Not Fully Realize Revenue Long-term Contracts Harm Business
Not Realize Anticipated Benefits Xenogen Acquisition Notes
Notes Adjusted Consolidated Statements Operations Notes Pro Forma Condensed Consolidated Balance Sheet
Notes Pro Forma Condensed Consolidated Statement Operations Notice Directors
Notice Holder Notice Meetings
Notice Person Communication Unlawful Notice Person Undeliverable Address
Notice Stockholders Notices
Novascreen Biosciences Corporation Now Therefore
Number 000-28229 Number Shares Common Stock Outstanding 2006 33932069
Number Shares Common Stock Outstanding 2008 48386705 Number Shares Common Stock Outstanding 2008 48432332
Number Shares Common Stock Outstanding 2009 48713421 Number Shares Common Stock Outstanding 2009 48998469
Number Shares Common Stock Outstanding 2009 49032477 Number Shares Each Option Agreement Shall State Pertains
Number Term Office Off-balance Sheet Arrangements
Officers Designated Open Sales Contracts
Operating Accounts Operating Activities
Operating Documents Optical Imaging
Option Exercise Vesting Option Exercises Restricted Stock Vested
Options Accessories Options Restricted Stock Activity
Order Organization
Organization Basis Presentation Other
Other Business Risks Other Committees
Other Compensation Other Compensation Benefits
Other Current Non-current Liabilities Other Events
Other Fees Other Income Expense
Other Income Expense Net Other Income Net
Other Information Other Matters
Other Officers Employees Agents Other Offices
Other Payment Except Expressly Provided Agreement Accelerate Accrual Other Provisions
Other Requirements Outplacement Services
Outstanding Equity Awards Year-end Overall Economic Outlook
Overview Overview 2006
Overview 2007 Ownership
Paragraph Lease Amended Read Entirety Follows Paragraph Shall Amended Deleting Existing Clause Such Replacing
Paragraph Shall Amended Deleting Sentence Such Replacing Following Park
Parties Party Information
Paula Cassidy Paying Proxy Solicitation
Payment Payment Interest Credit Extensions
Payment Landlords Costs Payments Account Real Estate Taxes
Pdq Product Line Divestiture Performance Bonus
Performance Graph Performance Measurement Comparison
Permitted Peter Mcaree
Phenotyping Place Meetings
Plan Term Plans
Positive Operating Cash Flows Reported Year-to-date Post-termination Compensation Benefits
Potential Payments Change Control Potential Payments Termination Change Control
Potential Payments Termination Without Cause After Change Control Potential Payments Termination Without Cause Prior After Change
Potential Payments Termination Without Cause Resignation Good Reason Powers
Powers Board Pre-approval Policies Procedures
Pre-commencement Communications Pursuant Rule 14d-2 Exchange Act Cfr Preferred Share Purchase Rights Plan
Premises Premises Rentable Area
Preparation Premises Presentation Todays Morgan Conference
Principal Accountant Fees Services Prior Facility Closures
Prior Leases Pro Forma Financial Information
Proceeding Proceedings Orders
Product Line Divestitures Product Revenue
Product Service Revenue Growth Product Support
Products Services Prohibited Transaction
Prohibition Project Assignment
Properties Property Equipment
Proposed Directors Plan Amended Proprietary Information
Proprietary Information Obligations Provisions Charter Documents Delaware Law Inhibit Takeover Limit
Provisions Incorporated Sublease Proxy
Proxy Properly Executed Voted Directed Direction Given Each Proxy Solicited Board Directors Annual Meeting 2007
Proxy Solicited Board Directors Annual Meeting 2008 Public Perception Ethical Social Issues Limit Discourage Mice
Publicity Purchase Price
Purpose Pursuant Securities Exchange Act 1934
Quantitative Qualitative Disclosures Market Risk Quorum
Quorum Voting Ratification Selection Independent Registered Public Accounting Firm
Reagents Reagents Bioware
Reagents Bioware Products Reason Changes Directors Compensation Required Vote Approval
Receiving Materials Recent Accounting Pronouncements
Recent Business Highlights Recent Highlight Closing Xenogen Acquisition
Recent Performance Trends Recital
Reclassifications Recognition Rights Nondisclosure
Registered Registered Office
Registered Stockholders Regular Meetings
Regulation Disclosure Release Adea Claims
Remedies Cumulative Specific Performance Removal
Report Audit Committee Board Directors Report Independent Registered Public Accounting Firm
Representatives Required Condition Premises Surrender
Required Condition Premises Surrender Lease Deleted Entirety Replaced Research
Research Development Research Development Expenses
Research Development Infrastructure Research Product Lines
Resignation Resignations
Responsibility Employment Liabilities Claims Restricted Cash
Restrictions Transfer Restructuring Activities
Restructuring Charge Restructuring Charges
Restructuring Charges Credits Restructuring Obligations
Results Results Operations 2007 2006
Results Operations 2008 Results Operations 2009
Results Operations Finan Cial Condition Results Operations Financial Condition
Return Client Property Return Property
Revenue 367million Increase Over 2006 Revenue Growth Xenogen Acquisition Complete
Revenue Growth Xenogen Ivis Canon Selects Caliper Diagnostics Revenue Guidance
Revenue Highlights Strategic Business Unit Revenue Microfluidics Business Continues Expand
Revenue Recognition Revenues Exceed Mid-point Guidance
Reversion Shares Share Reserve Revolving Advances
Revolving Credit Facility Revolving Line Maturity Date
Right Offer Rights Technologies Licensed Parties Not Within Control Without
Risk Factors Risk Management
Risks Related Owning Common Stock Robert Bishop Phd
Roskey Phd Royalties
Royalty Arrangements Royalty Commitments
Rule 13a-14 15d-14 Sale Reinforces Strategic Focus Enhances Cash Position
Sale Transferred Assets Sales Marketing
Sales Taxes Sarbanes-oxley Act 2002
Saving Clause Schedule 14a
Securities Authorized Issuance Equity Compensation Plans Securities Exchange Act 1934
Securities Law Compliance Securities Registered Pursuant Exchange Act
Security Security Deposit
Security Ownership Certain Beneficial Owners Management Related Stockholder See Accompanying Notes
See Reverse Voting Instructions Segment Reporting
Seller Seller Contract
Seller Employee Selling General Administrative Expenses
Separation Service Annual Maintenance Agreements
Service Revenue Service Rights
Services Severability
Severance Change Control Arrangements Severance Payment
Sfas 123r Share Reserve
Sharpens Growth Focus Strengthens Balance Sheet Reduces Costs Shipping Handling Fees Costs
Signage Signage Paragraph Lease Amended Adding Following End Sentence
Signature Signature Page Follows
Signatures Significant Concentrations Credit Other Risks
Solid Momentum Toward Cash Flow Breakeven Sotax Corporation
Source Shares Special Meetings
Specify Terms Conditions Stock Right Rights Granted Staccato Automated Workstations
Statement Position 97-2 Software Revenue Recognition Eitf 03-5 Statement Regarding Non-gaap Financial Measures
Stephen Creager Stock Options
Stock Price Extremely Volatile Lose Substantial Portion Investment Stock Subject Directors Plan
Stock-based Compensation Stockholder Approval
Stockholder Communications Board Directors Stockholder Proposals Due Next Annual Meeting
Stockholder Recommendations Nominations Directors Stockholder Record Shares Registered Name
Stockholder Rights Stockholders
Stockholders Equity Stockholders Record Shares Registered Name
Submission Matters Vote Security Holders Subsection
Subsequent Event Subsidiary
Success Depend Partly Ability Operate Without Infringing Misappropriating Successors Assigns Parties Interest
Sufficiency Transferred Assets Summary Compensation
Summary Gaap Financial Performance Summary Significant Accounting Principles
Supplemental Disclosure Cash Non-cash Activities Supplemental Non-gaap Financial Results
Surrender Premises Survival
Survival Representations Survival Rights
Surviving Termination Swing Space
Systems Assay Integration Table Con Tents
Table Cont Ents Table Content
Table Contents Taken Such Actions Necessary Give Bank Perfected Security
Tax Tax Fees
Tax Matters Tax Net Operating Losses Credit Carryforwards Expire Not
Tax Return Taxes Pensions
Technology Research Telecommunications
Telephone Meetings Temporary Permanent Closure Leased Facility Harm Operating Results
Tenant Tenants Default
Tenants Indemnity Tenants Insurance
Tenants Obligations Tenants Payment Operating Expenses
Tenants Proportionate Share Term
Term Agreement Term Option Participants Own
Term Termination Termination
Termination Client Termination Continuous Service
Termination Contractor Termination Contracts
Termination Non-renewal Large Contract Loss Significant Reduction Sales Termination Non-renewal Large Multi-year Contract Loss Significant Reduction
Terms Equity Awards Directors Plan Terrorist Acts War Natural Disasters Seriously Harm Business
Thomas Higgins Thomas Higgins Chief Financial Officer 508 497 2809
Time Notices Deemed Given Title Transferred Assets
Total Revenue Tpw Tablet Processing Workstation
Trademarks Transactional Agreements
Transactions Transferability
Transfers Triple Net Lease
Trust Bank Such Payment Shall Promptly Delivered Application Twister
Unable Meet Customer Demand Adversely Impact Financial Results Unable Meet Customer Demand Quality Expectations Adversely Impact
Undersigned Represents Warrants True Complete Correct Information Borrowing Unregistered Sales Equity Securities Proceeds
Unregistered Sales Securities Update Joint Proxy Statement Prospectus Dated 2006
Utilities Vacancies
Validation Services Valuation Intangibles
Van Billet Vitro Compound Profiling Services
Vivo Vivo Biophotonic Imaging Products Services Not Become Widely
Vivo Compound Profiling Analysis Vivo Optical Imaging Products Services Not Become Widely
Vote Vote Annual Meeting
Vote Internet Http Wwweproxycom Calp Quick Easy Immediate Vote Internet Wwweproxycom Calp Quick
Vote Mail Vote Phone Internet Please Not Mail Proxy Card
Vote Phone Toll Free 1-800-560-1965 Quick Vote Phone Toll Free 1-800-560-1965 Quick Easy Immediate
Vote Required Votes
Votes Counted Votes Needed Approve Each Proposal
Voting Rights Voting Securities Owned Corporation
Waiver Waiver Assignment Other Rights
Waiver Notice Waiver Subrogation
Warn Act Compliance Warrants
Warranty Obligation Warranty Obligations
Warranty Provision What Mean Receive Proxy Card
What Quorum Requirement What Return Proxy Card Not Make Specific Choices
What Voting Whereas
William Kruka Withholding Obligations
Witness Whereof Witness Whereof Parties Executed Amendment Date Written Above
Witness Whereof Undersigned Executed Asset Sale Purchase Agreement Xenogen Acquisition
Xenogen Corporation Xenogen Integration Completed Ahead Schedule
Xenogen Vivo Biophotonic Imaging Products Services Not Become Zephyr
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki